GSK

Glaxo May Settle 1,000 More Avandia Lawsuits, Attorney Says
Bloomberg Businessweek
Thu, 05/5/11 - 09:35 am
settlements
GSK
Avandia
diabetes
Glaxo's growth is not an accident: Andrew Witty, global CEO
Economic Times, India
Sat, 04/30/11 - 11:36 am
GSK
Andrew Witty
GlaxoSmithKline sales drop, outlook brightens
Marketwatch
Wed, 04/27/11 - 11:31 am
earnings
GSK
Regeneron, Glaxo gain in early action
Marketwatch
Wed, 04/27/11 - 11:30 am
Regeneron
GSK
Zaltrap
colorectal cancer
FDA approves GlaxoSmithKline drug Lamictal for seizures
Bizjournals.com
Tue, 04/26/11 - 03:02 pm
Lamictal
FDA
GSK
partial seizures
Glaxo and Valeant Respond to CRL
Yahoo/Zacks.com
Mon, 04/25/11 - 05:26 pm
GSK
Valeant Pharmaceuticals
Charles River Laboratories
ezogabine
GlaxoSmithKline Biologicals looking to acquire Biological E Limited's vaccine division
Invest In India
Sat, 04/23/11 - 11:14 am
GSK
Biological E
vaccines
Regulatory Update - GSK and Valeant Respond to FDA on Ezogabine
PharmaLive
Sat, 04/23/11 - 11:06 am
GSK
Valeant Pharmaceuticals
ezogabine
epilepsy
Pharma's Most Perilous Pipelines
Motley Fool
Sat, 04/23/11 - 10:58 am
Teva Pharmaceuticals
Eli Lilly
Novartis
GSK
AstraZeneca
Pfizer
Report: GSK mulls deal for India vaccines unit
Fierce Pharma
Thu, 04/21/11 - 11:49 am
vaccines
GSK
M&A
Biological E
India
How Do These Pharmas Really Boost Their Returns?
Motley Fool
Thu, 04/21/11 - 10:56 am
Merck
Pfizer
Abbott Laboratories
GSK
ROE
Dynavax gets $6M for start of human tests of lupus treatment
Bizjournals.com
Wed, 04/20/11 - 06:57 pm
lupus
GSK
Dynavax
DV1179
Valeant Pharmaceuticals, GlaxoSmithKline respond to FDA request on epilepsy drug
Yahoo/AP
Mon, 04/18/11 - 11:10 am
GSK
Valeant Pharmaceuticals
FDA
epilepsy
ezogabine
Glaxo Plans to Sell Alli Diet Pill, 18 Other Consumer Brands
Bloomberg
Fri, 04/15/11 - 11:24 am
GSK
Alli
diet drugs
Amarin: Positive ANCHOR Trial Data May Be Already Baked Into Its Price
Seeking Alpha
Fri, 04/15/11 - 09:46 am
ANCHOR
Amarin
GSK
dyslipidemia
AMR101
Human Genome Sciences Will Be Profitable, Eventually
Motley Fool
Thu, 04/14/11 - 10:33 pm
Human Genome Sciences
GSK
Benlysta
Bayer
ONYX Pharmaceuticals
Elan
Biogen Idec
FDA Urged To Ban Diet Pill Over Liver Damage
Pharmalot
Thu, 04/14/11 - 12:03 pm
FDA
Alli
Roche
Xenical
GSK
4-Star Stocks Poised to Pop: GlaxoSmithKline
Motley Fool
Tue, 04/12/11 - 03:25 pm
GSK
Approval In Hand, Does Xenoport Have The Legs To Run?
Investopedia
Mon, 04/11/11 - 12:16 pm
restless legs syndrome
XenoPort
GSK
Horizant
GSK Named As Bidder In Emerging Market Acquisition
Pharmaceutical Insight
Sat, 04/9/11 - 11:47 am
GSK
Biofarma

Pages